Literature DB >> 22106237

Functional and oncologic results of extended supracricoid partial laryngectomy.

Jun-Ook Park1, Young-Hoon Joo, Kwang-Jae Cho, Nam-Gyun Kim, Min-Sik Kim.   

Abstract

OBJECTIVE: To evaluate functional and oncologic results in patients who underwent unilateral arytenoidectomy during supracricoid partial laryngectomy.
DESIGN: Retrospective analysis of medical records.
SETTING: Tertiary care referral center. PATIENTS: One hundred sixteen patients who had received supracricoid partial laryngectomy. MAIN OUTCOME MEASURES: Functional and oncologic results in patients who received supracricoid partial laryngectomy with the extended procedure of unilateral arytenoidectomy.
RESULTS: There was a significantly higher rate of aspiration pneumonia (P = .002) and a longer delay of decannulation (P = .03) in the extended group. No significant differences were noted between the 2 groups in the scores for "normalcy of diet" (P = .68), "eating in public" (P = .65), or "understandability of speech" (P > .99) on the Performance Status Scale for Head and Neck Cancer Patients at the last follow-up visit. Five-year overall recurrence was 24.5% in the extended group. Five-year overall survival was 66.6%, and 5-year disease-specific survival was 72.1% in the extended group.
CONCLUSIONS: Resection of the arytenoids may interrupt physiologic airway protection in the early postoperative period, necessitating special caution to prevent aspiration pneumonia. However, extended supracricoid partial laryngectomy including arytenoidectomy allows for reasonable oncologic safety and avoidance of functional handicaps and social maladjustment.

Entities:  

Mesh:

Year:  2011        PMID: 22106237     DOI: 10.1001/archoto.2011.182

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  8 in total

Review 1.  Functional outcomes after supracricoid laryngectomy: what do we not know and what do we need to know?

Authors:  Antonio Schindler; Nicole Pizzorni; Francesco Mozzanica; Marco Fantini; Daniela Ginocchio; Andy Bertolin; Erika Crosetti; Giovanni Succo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-06       Impact factor: 2.503

2.  Analyses of functional and oncologic outcomes following supracricoid partial laryngectomy.

Authors:  Yan Wang; Xiaotian Li; Zimin Pan
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-31       Impact factor: 2.503

3.  Prevalence and associated factors of aspiration and severe dysphagia in asymptomatic patients in the late period after open partial laryngectomy: a videofluoroscopic evaluation.

Authors:  Andressa Silva de Freitas; Izabella C Santos; Cristina Furia; Rodrigo Dornelas; Ana Catarina Alves E Silva; Fernando Luiz Dias; Gil F Salles
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-04       Impact factor: 2.503

4.  Function preservation using transoral laser surgery for T2-T3 glottic cancer: oncologic, vocal, and swallowing outcomes.

Authors:  Giorgio Peretti; Cesare Piazza; Francesca Del Bon; Renzo Mora; Paola Grazioli; Diego Barbieri; Stefano Mangili; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-09       Impact factor: 2.503

5.  Supracricoid laryngectomies: oncological and functional results for 152 patients.

Authors:  C A Leone; P Capasso; G Russo; P D'Errico; P Cutillo; P Orabona
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-10       Impact factor: 2.124

6.  Supracricoid Laryngectomy: The Function of the Remaining Arytenoid in Voice and Swallowing.

Authors:  Elaine Cristina Pires Buzaneli; Marcia Simões Zenari; Marco Aurélio Vamondes Kulcsar; Rogerio A Dedivitis; Cláudio Roberto Cernea; Kátia Nemr
Journal:  Int Arch Otorhinolaryngol       Date:  2018-03-29

7.  Management of advanced laryngeal cancer.

Authors:  Patrick Sheahan
Journal:  Rambam Maimonides Med J       Date:  2014-04-28

8.  [Supracricoid partial laryngectomy (SCPL) with either cricohyoidoepiglottopexy (CHEP): our experience with 16 cases].

Authors:  Bouchaib Hemmaoui; Mohamed Sahli; Noureddine Errami; Ahmed Rouihi; Mohamed Habib Bahalou; Ilias Benchaifai; Amine Ennouali; Sara Britel; Ismail Nakkabi; Ali Jahidi; Mohamed Zalagh; Saloua Ouaraini; Fouad Benariba
Journal:  Pan Afr Med J       Date:  2017-07-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.